SKShoichiro Kanda

Shoichiro Kanda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shoichiro Kanda has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Graves’ Disease Mimicking Orthostatic Dysregulation in an Adolescent Girl: Findings on Active Standing Tests

    by Takuya Itayagoshi, Shoichiro Kanda, Haruka Shimizu, Moe Yoshimura, Ikuma Musha, Yuko Akioka, Toru Kikuchi

    Orthostatic dysregulation (OD) is common during adolescence and may present with dizziness, palpitations, fatigue, and difficulty getting up in the morning. These symptoms overlap with those of Graves’ disease, making differentiation challenging in some patients. A 14-year-old girl presented with headache, dizziness, palpitations, and difficulty getting up in the morning, with worsening symptoms during standing and walking. An active standing test reproduced her symptoms, including tachycardia, lower-extremity tremor, marked sweating, and nausea, and she was initially considered to have OD. Her resting heart rate was already elevated, and marked orthostatic tachycardia resembling postural orthostatic tachycardia syndrome (POTS) was observed during the test. However, thyroid function tests revealed severe hyperthyroidism, and positive thyroid-stimulating hormone receptor antibodies led to a diagnosis of Graves’ disease. Following treatment with methimazole, potassium iodide, and propranolol, her symptoms resolved. Propranolol was discontinued after one month. Repeat orthostatic testing after improvement of thyroid function no longer reproduced her symptoms or marked tachycardia. Graves’ disease may therefore mimic not only the clinical symptoms of OD but also POTS-like orthostatic tachycardia during orthostatic testing. Thyroid dysfunction may warrant consideration in patients with OD-like symptoms, particularly when accompanied by resting tachycardia, tremor, increased sweating, or weight loss.

  • Open Access

    A Bifid Eleventh Rib Presenting as a Dorsal Mass in an Infant

    by Yusuke Goto, Shoichiro Kanda, Satomi Kondo, Moe Yoshimura, Katsuhiko Tabata, Yuko Akioka, Naomi Ino

    Infantile dorsal masses arise from a wide range of congenital, inflammatory, and neoplastic conditions, and accurate diagnosis often depends on imaging. We report a 10-month-old boy who presented with a palpable left dorsal mass that was ultimately diagnosed as an isolated bifid 11th rib. Routine chest radiographs were inconclusive, whereas ultrasonography suggested an osseous lesion, an oblique rib radiograph localized the abnormality to the 11th rib, and three-dimensional computed tomography clearly demonstrated the bifid morphology. Magnetic resonance imaging (MRI) excluded an associated soft tissue lesion. The patient was managed conservatively. This case illustrates that a bifid 11th rib may present as a dorsal mass because of the posterior orientation of a floating rib and highlights the value of stepwise imaging, particularly three-dimensional computed tomography, for establishing the diagnosis when conventional imaging is inconclusive.

  • Open Access

    A non-invasive liquid biopsy resolves the diagnostic blind spot in chronic kidney disease

    by Tatsuya Nishimura, Yutaka Harita, Yosuke Hirakawa, Keiichi Takizawa, Jun Fujishiro, Sumito Ogawa, Yuko Kajiho, Shoichiro Kanda, Reiko Kushima, Tae Omori, et al.

    Chronic kidney disease is a major global health burden, and its early detection is critical for delaying progression to kidney failure using recently developed targeted therapies. However, current diagnostic screening relies heavily on blood markers that are confounded by muscle mass, and on urine tests that frequently miss structural damage occurring without protein leakage. This creates a critical diagnostic blind spot that hinders timely intervention. Here we show a non-invasive liquid biopsy platform that quantifies a specific protein marker, MUC1, on urinary extracellular vesicles to accurately assess renal parenchymal integrity. By bypassing the systemic metabolic noise of traditional blood tests, our assay provides a remarkably stable, person-specific functional signature. Following extensive validation across diverse cohorts, our longitudinal analysis demonstrated that the discrepancy between this novel urine-based readout and standard blood tests unmasks hidden renal vulnerability, successfully predicting rapid functional decline. By comprehensively evaluating both tubular and glomerular integrity from a single spot urine sample, these findings establish a completely non-invasive, highly scalable prescreening tool that resolves the diagnostic blind spot, enabling broader early detection strategies and ushering in a new era of proactive risk management.

  • Open Access

    Conservative Kidney Management (CKM) in a Child with End-Stage Renal Disease Secondary to Joubert Syndrome

    by Risa Makii, Shoichiro Kanda, Misako Nakamura, Tatsuya Nishimura, Mika Okutsu, Takeshi Nagasawa, Keiichi Takizawa, Hidehito Ota, Hironori Ebishima, Hiroshi Terashima, et al.

    Joubert症候群に起因する末期腎不全の9歳女児に対し,家族の意向を尊重しつつ,患者本人の最善の利益を考慮して保存的腎臓療法(conservative kidney management: CKM)を選択した.共同意思決定(shared decision making: SDM)に基づく方針決定は成人CKMと共通するが,小児では意思表出が困難なことが多く,検討を要する点となる.本症例では,臨床倫理コンサルテーションやセカンドオピニオンを通じて方針決定の透明性を担保することで,保護者による代理意思決定の倫理的妥当性を確保した.また病状の進行に伴い,在宅診療や学校との連携など支援体制の構築や,DNAR(do not attempt resuscitation)の取得を含む緩和ケアの導入といった包括的なケアを段階的に整備した.以上のようにCKMを実践するうえで,患者・家族・主治医・在宅診療医・看護師・薬剤師・訪問看護ステーション・ソーシャルワーカー・臨床倫理コンサルテーションチーム・学校教員・医療機器業者・小児腎移植/透析施設の医師などの多職種が継続的に連携することが不可欠だった.

  • Open Access

    Long-term kidney function stabilization with fludrocortisone in autosomal recessive renal tubular dysgenesis: a case report

    by Reina Sugita, Shoichiro Kanda, Keiichi Takizawa, Yuko Kajiho, Yutaka Harita

    Renal tubular dysgenesis (RTD) is a rare disorder characterized by impaired development of the proximal tubules and kidney dysfunction due to decreased fetal renal plasma flow and renin-angiotensin system (RAS) inhibition. Fetal anuria causes severe oligohydramnios and Potter sequence, and most patients die within days after birth due to refractory hypotension, anuria, and respiratory distress. While vasopressin and fludrocortisone therapy have been reported, the long-term efficacy remains unclear due to the rarity of survivors. We report a 10-year-old girl with autosomal recessive renal tubular dysgenesis (ARRTD), a genetic form of RTD caused by mutations in RAS-related genes. She initially experienced recurrent dehydration, electrolyte abnormalities, and kidney dysfunction due to polyuria but showed long-term improvement following fludrocortisone therapy.

  • Open Access

    Successful Treatment of Growing Renal Angiomyolipomas With Low‐Dose Everolimus in a School‐Aged Child With Tuberous Sclerosis Complex

    by Satoshi Senoo, Shoichiro Kanda, Keiichi Takizawa, Hiroshi Terashima, Yuko Kajiho, Yutaka Harita

    Renal angiomyolipomas (AMLs) are a common renal manifestation in tuberous sclerosis complex (TSC), occurring in 50%–85% of cases. Even in asymptomatic individuals, treatment is often initiated based on AML size, with mTOR inhibitors being the primary medical therapy. AMLs tend to enlarge with age, and treatment during school age is rare. Secondary AML shrinkage in paediatric TSC patients has been reported who received everolimus for subependymal giant cell astrocytomas (SEGA) or epilepsy, but studies on its direct use for AMLs in paediatric cases remain limited. A 9‐year‐old girl born to a mother with TSC was diagnosed at birth due to cardiac rhabdomyomas, cortical tubers, and Shagreen patches. At the age of 4, ultrasound detected multiple AMLs in both kidneys, with the largest lesions measuring 2.3 cm in the right kidney and 1.6 cm in the left. By the age of 7, MRI showed further growth to 4.8 cm. Despite the absence of symptoms, the risk of haemorrhage led to treatment initiation. Everolimus was started at 1.0 mg/day (1.3 mg/m 2 /day), significantly lower than the standard 4.5 mg/m 2 /day. Trough levels remained below the target range, yet AMLs showed a shrinking tendency, with MRI at age 9 revealing a reduction in the largest AML to 2.4 cm. Stomatitis occurred intermittently, but no serious adverse effects were observed. This case suggests that low‐dose everolimus can effectively reduce AML size while minimising adverse effects, highlighting its potential as a treatment option for AMLs in paediatric TSC patients.


  • Open Access

    Renal and gastrointestinal complications following tosufloxacin therapy for suspected mycoplasma infection in a 10-year-old child

    by Shigehiro Sainokami, Hirofumi Watanabe, Shoichiro Kanda, Natsuho Adachi, Hiroyuki Tanaka, Keiichi Takizawa, Naoko Sone, Yuko Kajiho, Akiko Kinumaki, Yoshifumi Morita, et al.

    Tosufloxacin, a fluoroquinolone antibiotic, is increasingly prescribed for pediatric patients, particularly for macrolide-resistant Mycoplasma pneumoniae infections in Japan. While its efficacy is well-documented, adverse effects such as renal impairment and gastrointestinal symptoms have raised growing concerns. We report a case of a 10-year-old girl who developed sequential symptoms following tosufloxacin administration. On the day after starting tosufloxacin, she experienced right-sided flank pain, followed by the onset of gastrointestinal symptoms, including abdominal pain, diarrhea, and vomiting, on the subsequent day. Contrast-enhanced computed tomography revealed increased fatty tissue opacity surrounding the kidney and duodenal wall thickening, suggestive of localized inflammation extending from the kidney to adjacent structures. Urine microscopy demonstrated needle- and sea urchin-shaped drug crystals, strongly implicating tosufloxacin in the development of renal and gastrointestinal symptoms. This case provides the first evidence suggesting that kidney inflammation may contribute to gastrointestinal symptom onset via localized inflammatory extension. The patient’s symptoms resolved promptly with the discontinuation of tosufloxacin and supportive care. This report underscores the importance of monitoring pediatric patients for renal and gastrointestinal adverse effects following tosufloxacin administration.


  • Open Access

    Rotavirus-Associated Myositis in a 12-Year-Old Child

    by Arisa Hayashi, Mika Ukai, Shoichiro Kanda, Keiichi Takizawa, Akiko Kinumaki

    Rotavirus infection is a common cause of pediatric gastroenteritis, often self-limited but occasionally associated with extraintestinal complications. This report describes a 12-year-old vaccinated girl who presented with acute gastroenteritis and an incidental elevation of serum creatine kinase (CK). Despite the absence of muscle pain or weakness during hospitalization, laboratory findings indicated skeletal muscle involvement, with elevated CK and aldolase levels, and a predominance of CK-MM isoenzyme. Myocardial involvement and rhabdomyolysis were ruled out. The patient recovered with supportive care, and CK levels normalized after discharge, although she reported mild post-discharge fatigue. Rotavirus-associated myositis is rare and likely underrecognized, particularly in young children who may not verbalize muscle symptoms. This case highlights the importance of considering myositis in patients with elevated CK during rotavirus infection, even in the absence of overt muscular symptoms.

  • Open Access

    Long-Term Kidney Function Stabilization with Fludrocortisone in Autosomal Recessive Tubular Dysgenesis: A Case Report

    by Shoichiro Kanda, Reina Sugita, Keiichi Takizawa, Yuko Kajiho, Yutaka Harita

    Renal tubular dysgenesis (RTD) is a rare disorder characterized by impaired development of the proximal tubules and renal dysfunction due to decreased fetal renal plasma flow and renin-angiotensin system (RAS) inhibition. Fetal anuria causes severe oligohydramnios and Potter sequence, and most patients die within days after birth due to refractory hypotension, anuria, and respiratory distress. While vasopressin and fludrocortisone therapy have been reported, the long-term efficacy remains unclear due to the rarity of survivors. We report a 10-year-old girl with autosomal recessive renal tubular dysgenesis (ARRTD), a genetic form of RTD caused by mutations in RAS-related genes. She initially experienced recurrent dehydration, electrolyte abnormalities, and renal dysfunction due to polyuria, but showed long-term improvement following fludrocortisone therapy.

  • Open Access

    A Case of Orbital Cellulitis in a Seven-Year-Old Girl: The Diagnostic Significance of Intraorbital Air on Contrast-Enhanced CT

    by Alice Kodama, Ryutaro Ohira, Shoichiro Kanda, Keiichi Takizawa, Akiko Kinumaki

    Orbital and periorbital cellulitis are common pediatric infections requiring accurate differentiation, as orbital cellulitis can lead to severe complications if left untreated. A seven-year-old girl with a history of group A β-hemolytic Streptococcus (GAS) infection six months earlier presented with fever and progressive periorbital swelling. Differentiation between orbital and periorbital cellulitis based on physical examination alone was challenging due to the absence of proptosis and ophthalmoplegia. Contrast-enhanced CT revealed left-sided sinusitis, fat stranding extending beyond the orbital septum, partial erosion of the lamina papyracea, and intraorbital gas, confirming orbital cellulitis. Broad-spectrum antibiotics, cefotaxime (300 mg/kg/day), clindamycin (900 mg/day), and vancomycin (1500 mg/day), were administered, leading to rapid clinical improvement. Moraxella catarrhalis was identified from nasal and ocular discharge cultures, and the patient fully recovered after three weeks of antibiotic therapy without surgical intervention. This case highlights the importance of contrast-enhanced CT in distinguishing orbital from periorbital cellulitis, especially in cases lacking classical orbital findings. The presence of intraorbital gas served as a key diagnostic clue, emphasizing the need for early imaging in suspected orbital cellulitis to guide appropriate management. In particular, this case demonstrates that careful assessment of symptom presentation and clinical progression can support early consideration of orbital involvement and timely decision-making regarding CT imaging.